THIAZOLIDINEDIONES

This publication has 43 references indexed in Scilit:

• Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone
  Diabetes Care, 1997
• Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM
  Diabetes, 1996
• Inhibition of oxidation of low density lipoprotein by troglitazone
  Atherosclerosis, 1996
• Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.
  Journal of Clinical Investigation, 1995
• Effects of a New Oral Hypoglycaemic Agent (CS-045) on Metabolic Abnormalities and Insulin Resistance in Type 2 Diabetes
  Diabetic Medicine, 1994
• Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts
  Diabetes, 1994
• Thiazolidinediones (AD-4833 and CS-045) Improve Hepatic Insulin Resistance in Streptozotocin-Induced Diabetic Rats.
  Endocrine Journal, 1993
• Pathogenesis of NIDDM: A Balanced Overview
  Diabetes Care, 1992
• Studies on Hindered Phenols and Analogues. V. Synthesis, Identification, and Antidiabetic Activity of the Glucuronide of CS-045.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
• Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1982